Effect of 2-methoxyestradiol on the growth of methyl-nitroso-urea (MNU)-induced rat mammary carcinoma

Journal of Steroid Biochemistry and Molecular Biology

Volumn 84, Issue 1, 2003, Pages 51-56

  Lippert, T H ^a   Adlercreutz, H ^b   Berger, M R ^c   Seeger, H ^a   Elger, W ^d   Mueck, A O ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d EnTec GmbH   (Germany)

Author keywords

2 Methoxyestradiol; Rat mammary carcinoma; Urinary estrogen metabolites

Indexed keywords

2 METHOXYESTRADIOL; ESTRADIOL DERIVATIVE; METHYLNITROSOUREA; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ESTROGEN METABOLISM; FEMALE; HORMONE URINE LEVEL; METABOLITE; NONHUMAN; OSMOTIC PUMP; RAT;

ANIMALIA;

EID: 0344923319     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00268-6     Document Type: Article

References (9)

1. Lippert T.H., Seeger H., Mueck A.O. The impact of endogenous estradiol metabolites on carcinogenesis. Steroids. 65:2000;357-369.
2. Fotsis T., Zhang Y., Pepper M.S., Adlercreutz H., Montesano R., Nawroth P.P., Schweigerer L. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature. 368:1994;237-239.
3. Fotsis T., Adlercreutz H. The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS-I. Quantitation of estrogens after initial hydrolysis of conjugates. J. Steroid Biochem. 28:1987a;203-213.
4. Adlercreutz H., Fotsis T., Bannwart C., Wähälä K., Brunow G., Haser T. Isotope dilution gas chromatographic-mass spectrometric method for the determination of lignans and isoflavonoids in human urine, including identification of genistein. Clin. Chim. Acta. 199:1991;263-278.
5. Hyman B., Muss M.D. Endocrine therapy for advanced breast cancer: a review. Breast Cancer Res. Treat. 21:1992;15-26.
6. Zhu B.T., Conney A.H. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res. 58:1998;2269-2277.
7. Lippert C., Seeger H., Mueck A.O., Lippert T.H. The effects of A-ring and D-ring metabolites of estradiol on the proliferation of vascular endothelial cells. Life Sci. 67:2000;1653-1658.
8. Longcope C., Flood C., Femino A., Williams K.I.H. Metabolism of 2-methoxyestrone in normal men. J. Clin. Endocrinol. Metab. 57:1983;277-282.
9. Adlercreutz H., Gorbach S.L., Goldin B.R., Woods M.N., Dwyer J.T., Höckerstedt K., Wähälä K., Hase T., Hämäläinen E., Fotsis T. Diet and urinary estrogen profile in various populations. Polycyclic Aromat. Compd. 6:1994;261-273.